DIABNEXT
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | - | ||
* | N/A | Acquisition | |
Total Funding | - |
Recent News about DIABNEXT
EditDiabnext is a healthcare technology company specializing in automated monitoring solutions for diabetics. The company operates in the medical devices and digital health market, providing tools that automatically record insulin and blood glucose levels. Diabnext serves both individual patients and healthcare providers by offering products like the DIABNEXT Pro, which allows for comprehensive data tracking and personalized therapeutic information. The business model is centered around the sale of its medical devices and subscription-based services for data management and patient care. Revenue is generated through direct sales of devices such as the Insulin Pen C3, various glucometers, and through ongoing service subscriptions for data management and patient monitoring.
Keywords: diabetes, insulin monitoring, blood glucose, medical devices, digital health, patient care, data management, healthcare providers, automated recording, therapeutic information.